{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:20:38Z","timestamp":1769556038596,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.pnpbp.2009.11.024","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T09:43:27Z","timestamp":1259919807000},"page":"303-307","source":"Crossref","is-referenced-by-count":43,"title":["Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients"],"prefix":"10.1016","volume":"34","author":[{"given":"Cedo","family":"Miljevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Nikolic-Kokic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Niketic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusica","family":"Lecic-Tosevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihajlo B.","family":"Spasic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pnpbp.2009.11.024_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/32.5.805","article-title":"Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients","volume":"32","author":"Abdalla","year":"1986","journal-title":"Clin Chem"},{"issue":"12","key":"10.1016\/j.pnpbp.2009.11.024_bib2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1515\/CCLM.2000.201","article-title":"Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients","volume":"38","author":"Altuntas","year":"2000","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"10.1016\/j.pnpbp.2009.11.024_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","author":"Anonymous","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0278-5846(98)00089-X","article-title":"Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan","volume":"23","author":"Aymard","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2009.11.024_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pnpbp.2007.08.003","article-title":"Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings","volume":"32","author":"Ben Othmen","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2009.11.024_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/152308603764816569","article-title":"Selenium-dependent enzymes in endothelial cell function","volume":"5","author":"Brigelius-Flohe","year":"2003","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0003-2670(61)80041-X","article-title":"Micromethod for lipid phosphorus determination","volume":"24","author":"Butcher","year":"1961","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0924-977X(99)00033-4","article-title":"Cytochrome P450 and therapeutic drug monitoring with respect to clozapine","volume":"9","author":"Buur-Rasmussen","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2009.11.024_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2007.12.025","article-title":"Free radical metabolism in human erythrocytes","volume":"390","author":"Cimen","year":"2008","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.pnpbp.2009.11.024_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/hmg\/5.2.283","article-title":"Elevation in the ratio of Cu\/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide","volume":"5","author":"de Haan","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib11","first-page":"121","article-title":"Oxidative stress and antioxidant defense markers in the population of Serbia and Montenegro","volume":"39","author":"Djujic","year":"2003","journal-title":"Iugosl Physiol Pharmacol Acta"},{"issue":"12","key":"10.1016\/j.pnpbp.2009.11.024_bib12","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1249\/01.MSS.0000147632.17450.FF","article-title":"Oxidative stress responses in older men during endurance training and detraining","volume":"36","author":"Fatouros","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0013-7006(06)76151-6","article-title":"Oxidative stress involvement in schizophrenia pathophysiology: a review","volume":"32","author":"Fendri","year":"2006","journal-title":"Encephale"},{"issue":"3","key":"10.1016\/j.pnpbp.2009.11.024_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.pnpbp.2005.11.009","article-title":"Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine","volume":"30","author":"Gama","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib15","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1176\/ajp.156.8.1270","article-title":"Clozapine-associated elevation in serum triglycerides","volume":"156","author":"Gaulin","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib16","first-page":"2070","article-title":"Superoxide dismutase 1 and glutathione peroxidase levels in erythrocytes of adult schizophrenics","volume":"7","author":"Golse","year":"1978","journal-title":"Nouv Presse Med"},{"issue":"1","key":"10.1016\/j.pnpbp.2009.11.024_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.mp.4000789","article-title":"Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia","volume":"6","author":"Herken","year":"2001","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2009.11.024_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cbf.940","article-title":"Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder","volume":"20","author":"Kuloglu","year":"2002","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2003.09.010","article-title":"What's atypical about atypical antipsychotic drugs?","volume":"4","author":"Meltzer","year":"2004","journal-title":"Curr Op Pharm"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","article-title":"The effects of antipsychotic therapy on serum lipids: a comprehensive review","volume":"70","author":"Meyer","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib21","article-title":"Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication","author":"Miljevic","year":"2009","journal-title":"Psychiatry Res"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2009.11.024_bib22","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbrc.2006.06.199","article-title":"Could cholesterol bound to haemoglobin be a missing link for the occasional inverse relationship between superoxide dismutase and glutathione peroxidase activities?","volume":"348","author":"Nikolic","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pnpbp.2009.11.024_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00394-008-0705-z","article-title":"Dietary lipid intake influences the level of cholesterol bound to haemoglobin in human erythrocytes","volume":"47","author":"Nikolic","year":"2008","journal-title":"Eur J Nutr"},{"issue":"5","key":"10.1016\/j.pnpbp.2009.11.024_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/CCLM.2006.111","article-title":"Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients","volume":"44","author":"Nikolic-Kokic","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/clinchem\/44.5.924","article-title":"Antioxidant enzymes and fatty acid status in erythrocytes of Down syndrome patients","volume":"44","author":"Pastor","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpsychires.2006.01.011","article-title":"Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"41","author":"Pillai","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pbb.2004.05.018","article-title":"Haloperidol- and clozapine-induced oxidative stress in the rat brain","volume":"78","author":"Polydoro","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pnpbp.2009.11.024_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2009.11.024_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0006-3223(91)90298-Z","article-title":"Enzymes of the antioxidant defense system in chronic schizophrenic patients","volume":"30","author":"Reddy","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2009.11.024_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diabet.2007.01.003","article-title":"Abnormal glucose metabolism in patients treated with antipsychotics","volume":"33","author":"Scheen","year":"2007","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib33","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0006-291X(75)90763-9","article-title":"Increase in glutathione peroxidase activity in erythrocytes from trisomy 21 subjects","volume":"67","author":"Sinet","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1042\/bj2200685","article-title":"Oxidative interactions between haemoglobin and membrane lipid A liposome model","volume":"220","author":"Szebeni","year":"1984","journal-title":"Biochem J"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/026988110001400411","article-title":"Refractory schizophrenia and atypical antipsychotics","volume":"14","author":"Taylor","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib36","series-title":"Methods in enzymology","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0076-6879(81)76152-4","article-title":"Hemoglobinometry in human blood","author":"Tentori","year":"1981"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM197102182840703","article-title":"Hemoglobin components in patients with diabetes mellitus","volume":"284","author":"Trivelli","year":"1971","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pnpbp.2009.11.024_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ajh.20738","article-title":"Methemoglobin\u2014it's not just blue: a concise review","volume":"82","author":"Umbreit","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2125.2003.01773.x","article-title":"Low blood selenium concentrations in schizophrenic patients on clozapine","volume":"55","author":"Vaddadi","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.pnpbp.2009.11.024_bib40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1017\/S1461145708008882","article-title":"Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations","volume":"11","author":"Walss-Bass","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.pnpbp.2009.11.024_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3956(98)00028-4","article-title":"Effects of haloperidol on antioxidant defense system enzymes in schizophrenia","volume":"32","author":"Yao","year":"1998","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.pnpbp.2009.11.024_bib42","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0006-3223(98)00184-X","article-title":"Human plasma glutathione peroxidase and symptom severity in schizophrenia","volume":"45","author":"Yao","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.024_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/oxfordjournals.schbul.a033333","article-title":"Management of the adverse effects of clozapine","volume":"24","author":"Young","year":"1998","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.pnpbp.2009.11.024_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-1781(02)00303-7","article-title":"Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms","volume":"117","author":"Zhang","year":"2003","journal-title":"Psychiatry Res"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2009.11.024_bib45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr Res"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609004102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609004102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T19:45:18Z","timestamp":1685216718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584609004102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0278584609004102"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2009.11.024","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}